Gedeon Richter

Gedeon Richter is a company listed under the stock ticker RGEDF (HU).

Gedeon Richter has a direct presence in 3 countries.

They are in:

• Biotechnology67%
• Pharmaceuticals33%

View the org chart displaying its 30 main executives

Most searched biographies at Gedeon Richter

• Gabor Orband, Chief Executive Officer and Director
• Erik Bogsch, Chairman of the Board
• Balázs Szepesi, Director

Create your alert
to follow the executive moves at Gedeon Richter.

Gedeon Richter has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Gedeon Richter

• Impresszum
• News

Social media about Gedeon Richter

• Gedeon Richter on Wikipedia, Google News & Yahoo Finance
• Gedeon Richter on LinkedIn, Twitter & YouTube

Contact by email its executives including Gabor Orband

Call Gedeon Richter at +36 ...

View the org chart

Register to receive your alert

Report an error